デフォルト表紙
市場調査レポート
商品コード
1425919

ビタミンD療法の世界市場レポート2024

Vitamin D Therapy Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
ビタミンD療法の世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

ビタミンD療法の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には12.9%の年間複合成長率(CAGR)で48億米ドルに成長すると予想されます。予測期間中に予想される成長は、意識と教育における継続的な取り組み、高齢者人口の増加、慢性疾患管理におけるビタミンDの統合、製剤の技術的進歩、世界の健康への取り組み、個別化された栄養への注目の高まりによるものと考えられます。予測期間中に予想される主な動向としては、骨の健康を超えた用途の拡大、サプリメントの促進を推進する政府の取り組み、製剤と送達方法の革新、臨床調査と科学的根拠に基づいた実践への重点の集中、世界市場の拡大などが挙げられます。これらの動向は、 ビタミンD療法の多面的な利点がより広く認識され、さまざまな健康やウェルネスの状況での応用がますます重視されていることを示しています。

栄養失調症例の予測増加により、ビタミンD療法市場の大幅な成長が促進されると予想されます。栄養摂取の欠乏または過剰を含む栄養失調は、特に入院患者の間でビタミンD欠乏症が蔓延する一因となっており、適切なビタミンD治療がなければ長期死亡率の上昇につながっています。世界保健機関による2021年6月の記事は、2020年には約19億人の成人が過体重または肥満に直面し、4億6,200万人が低体重状態に陥っていると引用し、世界の問題を強調しました。さらに、推定1億4,900万人の5歳未満の子供が発育不全に陥り、4,500万人が発育不全に陥っていると推定されています。 3,890万人が過体重または肥満に直面しています。この栄養失調の蔓延は、ビタミンD療法ソリューションに対する需要の高まりの背後にある原動力を強調しています。

慢性疾患の増加により、ビタミンD療法の需要が高まることが予想されます。アルツハイマー病、関節リウマチ、パーキンソン病、がんなどの慢性疾患は、ビタミンD欠乏症と関連しています。調査では、ビタミンDレベルの不足が心血管疾患、糖尿病、特定のがんなどのさまざまな慢性疾患のリスク増加と一貫して関連付けられています。注目すべきことに、国立がん研究所(NCI)は、2020年に米国だけで新たながん症例数が1,806,590人、関連死亡者数が606,520人であると報告しました。さらに、予測では、2040年までに新たながん症例数が年間2,950万人に急増し、死亡者数は1,640万人に達することが示されています。ビタミンDは免疫調節、心血管の健康、代謝機能において重要な役割を果たしているため、慢性疾患の管理にはビタミンDの補給が不可欠となり、ビタミンD療法市場の成長を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のビタミンD療法市場、投与別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • 世界のビタミンD療法市場、購入別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 一般用医薬品
  • 処方薬
  • 世界のビタミンD療法市場、年齢層別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 子供
  • 大人
  • シニア成人
  • 世界のビタミンD療法市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 骨粗鬆症
  • くる病
  • 皮膚疾患
  • 筋力低下
  • 自己免疫疾患

第7章 地域および国の分析

  • 世界のビタミンD療法市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のビタミンD療法市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ビタミンD療法市場の競合情勢
  • ビタミンD療法市場の企業プロファイル
    • Abbott Laboratories
    • Sanofi SA
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Merck &Co Inc

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r13151

Vitamin D Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vitamin d therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vitamin d therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vitamin d therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Administration: Oral; Parenteral
  • 2) By Purchasing: OTC Drugs; Prescription Drugs
  • 3) By Age Group: Children; Adults; Senior Adults
  • 4) By Application: Osteoporosis; Rickets; Skin Diseases; Muscle Weakness; Autoimmune Disorders
  • Companies Mentioned: Abbott Laboratories; Sanofi SA; GlaxoSmithKline PLC; Pfizer Inc.; Merck & Co Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Vitamin D therapy involves the use of supplements commonly prescribed to treat and prevent vitamin D deficiency. These supplements contribute to the regulation of calcium and phosphorus levels in the body and play a crucial role in maintaining proper bone structure. Vitamin D therapy is also considered in cases of depression where a vitamin D deficiency is identified.

The administration methods for vitamin D therapy include oral and parenteral routes. Oral administration involves ingestion through the mouth. Various purchasing options are available, including over-the-counter (OTC) drugs and prescription drugs. These supplements cater to diverse age groups, including children, adults, and senior citizens, addressing conditions such as osteoporosis, rickets, skin diseases, muscle weakness, and autoimmune disorders.

The vitamin D therapy market research report is one of a series of new reports from The Business Research Company that provides vitamin D therapy market statistics, including vitamin D therapy industry global market size, regional shares, competitors with vitamin D therapy market share, detailed vitamin D therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the vitamin D therapy industry. This vitamin D therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vitamin d therapy market size has grown rapidly in recent years. It will grow from $2.63 billion in 2023 to $2.95 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The growth observed in the historical period can be attributed to several factors, including the increasing awareness of vitamin D deficiency, a rise in the incidence of bone disorders, the aging population, and the prevalence of osteoporosis. Additionally, scientific research highlighting the benefits of vitamin D, an increase in lifestyle-related diseases, and medical recommendations for supplementation have played a significant role in the historical growth of vitamin D therapy.

The vitamin d therapy market size is expected to see rapid growth in the next few years. It will grow to $4.80 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The anticipated growth in the forecast period can be attributed to ongoing efforts in awareness and education, a rising geriatric population, the integration of vitamin D in chronic disease management, technological advances in formulations, global health initiatives, and an increased focus on personalized nutrition. Major trends expected in the forecast period include the expansion of applications beyond bone health, government initiatives promoting supplementation, innovations in formulations and delivery methods, a heightened focus on clinical research and evidence-based practices, and the expansion of the global market. These trends indicate a broader recognition of the multifaceted benefits of vitamin D therapy and an increased emphasis on its applications in various health and wellness contexts.

The projected increase in malnutrition cases is set to drive substantial growth within the vitamin D therapy market. Malnutrition, encompassing deficiencies or excesses in nutrient intake, contributes to a widespread prevalence of vitamin D deficiency, particularly among inpatients, which is linked to heightened long-term mortality rates without adequate vitamin D treatment. An article by the World Health Organization in June 2021 highlighted the global issue, citing approximately 1.9 billion adults facing overweight or obesity, alongside 462 million experiencing underweight conditions in 2020. Moreover, an estimated 149 million children under 5 years old were stunted, 45 million wasted, and 38.9 million faced overweight or obesity. This mounting prevalence of malnutrition cases underscores the driving force behind the escalating demand for vitamin D therapy solutions.

The rise in chronic diseases is anticipated to propel the demand for vitamin D therapy. Chronic conditions like Alzheimer's disease, rheumatoid arthritis, Parkinson's disease, and cancer exhibit associations with vitamin D deficiency. Research consistently links inadequate vitamin D levels to increased risks of various chronic ailments such as cardiovascular diseases, diabetes, and certain cancers. Notably, the National Cancer Institute (NCI) reported 1,806,590 new cancer cases and 606,520 related deaths in the US alone in 2020. Furthermore, projections indicate a surge to 29.5 million new cancer cases annually by 2040, with 16.4 million deaths. With vitamin D playing a vital role in immune regulation, cardiovascular health, and metabolic function, its supplementation becomes crucial in managing chronic diseases, thus fostering the growth of the vitamin D therapy market.

Product innovation stands out as a significant trend shaping the vitamin D therapy market. Leading companies in this domain are actively introducing novel products to reinforce their market position. An exemplar of this trend is DSM Pharma Solutions, a Netherlands-based pharmaceutical company, launching a new vitamin D3 powder in February 2021. Vitamin D3, essential for bone and muscle health and bolstering immune function, is often challenging to acquire through limited food sources or sunlight exposure. DSM Pharma Solutions' innovative vitamin D3 powder aims to address these challenges, providing an efficient solution to achieve healthy vitamin D levels in the bloodstream. This emphasis on innovation characterizes the ongoing evolution and growth within the vitamin D therapy market.

Prominent players within the vitamin D therapy market are actively pursuing partnerships to fortify their market presence and strategic positioning. These partnerships signify structured affiliations between commercial enterprises, typically established through business agreements or contracts. An illustration of this strategy is Dishman Carbogen Amcis Ltd., an India-based pharmaceutical company, which forged a partnership with Boston University School of Medicine in May 2021. This collaborative effort aims to delve into insights regarding the treatment of vitamin D deficiency in obesity and fat malabsorption syndromes, ultimately aiming to develop and provide effective treatments for patients. Boston University School of Medicine, based in the US, brings its expertise to this strategic collaboration.

In June 2022, Nestle Health Science, a Switzerland-based nutritional science company, made an undisclosed acquisition of The Better Health Company (TBHC). This strategic acquisition is anticipated to synergize with Nestle's global portfolio, specifically enhancing its active lifestyle and health & wellness nutrition brands. Additionally, it positions Nestle Health Science to expedite growth by leveraging TBHC's manufacturing facility in Auckland, facilitating the swift introduction of new products into local markets. The Better Health Company, based in the US, brings its expertise in natural health products to complement Nestle's strategic objectives, signaling a strategic move towards bolstering their market presence and product offerings in the health and wellness domain.

Major companies operating in the vitamin d therapy market report are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

North America was the largest region in the vitamin D therapy market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin d therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vitamin d therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vitamin D therapy market consists of sales of plain vitamin D therapy and active vitamin D analog (or D-hormone) therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Vitamin D Therapy Market Characteristics

3. Vitamin D Therapy Market Trends And Strategies

4. Vitamin D Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Vitamin D Therapy Market Size and Growth

  • 5.1. Global Vitamin D Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Vitamin D Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Vitamin D Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Vitamin D Therapy Market Segmentation

  • 6.1. Global Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • 6.2. Global Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • OTC Drugs
  • Prescription Grugs
  • 6.3. Global Vitamin D Therapy Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Children
  • Adults
  • Senior Adults
  • 6.4. Global Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Osteoporosis
  • Rickets
  • Skin Diseases
  • Muscle Weakness
  • Autoimmune Disorders

7. Vitamin D Therapy Market Regional And Country Analysis

  • 7.1. Global Vitamin D Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Vitamin D Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Vitamin D Therapy Market

  • 8.1. Asia-Pacific Vitamin D Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Vitamin D Therapy Market

  • 9.1. China Vitamin D Therapy Market Overview
  • 9.2. China Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Vitamin D Therapy Market

  • 10.1. India Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Vitamin D Therapy Market

  • 11.1. Japan Vitamin D Therapy Market Overview
  • 11.2. Japan Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Vitamin D Therapy Market

  • 12.1. Australia Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Vitamin D Therapy Market

  • 13.1. Indonesia Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Vitamin D Therapy Market

  • 14.1. South Korea Vitamin D Therapy Market Overview
  • 14.2. South Korea Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Vitamin D Therapy Market

  • 15.1. Western Europe Vitamin D Therapy Market Overview
  • 15.2. Western Europe Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Vitamin D Therapy Market

  • 16.1. UK Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Vitamin D Therapy Market

  • 17.1. Germany Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Vitamin D Therapy Market

  • 18.1. France Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Vitamin D Therapy Market

  • 19.1. Italy Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Vitamin D Therapy Market

  • 20.1. Spain Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Vitamin D Therapy Market

  • 21.1. Eastern Europe Vitamin D Therapy Market Overview
  • 21.2. Eastern Europe Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Vitamin D Therapy Market

  • 22.1. Russia Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Vitamin D Therapy Market

  • 23.1. North America Vitamin D Therapy Market Overview
  • 23.2. North America Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Vitamin D Therapy Market

  • 24.1. USA Vitamin D Therapy Market Overview
  • 24.2. USA Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Vitamin D Therapy Market

  • 25.1. Canada Vitamin D Therapy Market Overview
  • 25.2. Canada Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Vitamin D Therapy Market

  • 26.1. South America Vitamin D Therapy Market Overview
  • 26.2. South America Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Vitamin D Therapy Market

  • 27.1. Brazil Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Vitamin D Therapy Market

  • 28.1. Middle East Vitamin D Therapy Market Overview
  • 28.2. Middle East Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Vitamin D Therapy Market

  • 29.1. Africa Vitamin D Therapy Market Overview
  • 29.2. Africa Vitamin D Therapy Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Vitamin D Therapy Market, Segmentation By Purchasing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Vitamin D Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Vitamin D Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Vitamin D Therapy Market Competitive Landscape
  • 30.2. Vitamin D Therapy Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi SA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GlaxoSmithKline plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pfizer Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merck & Co Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Vitamin D Therapy Market Competitive Benchmarking

32. Global Vitamin D Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Vitamin D Therapy Market

34. Vitamin D Therapy Market Future Outlook and Potential Analysis

  • 34.1 Vitamin D Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Vitamin D Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Vitamin D Therapy Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer